Targeted News Service

Menopause expert can discuss newly FDA-approved non-hormonal hot-flash drug
October 27, 2025

EVANSTON, Illinois, Oct. 27 -- Northwestern University posted the following news release:

* * *

Menopause expert can discuss newly FDA-approved non-hormonal hot-flash drug

*

* Hot flashes are linked to insomnia, heart disease, weight gain, sexual dysfunction, bone loss

* Newly approved drug decreases hot flashes by an average of 67%

* Elinzanetant 'comes out ahead' of other FDA-approved non-hormonal drug . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form